JP2010529950A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010529950A5 JP2010529950A5 JP2010507772A JP2010507772A JP2010529950A5 JP 2010529950 A5 JP2010529950 A5 JP 2010529950A5 JP 2010507772 A JP2010507772 A JP 2010507772A JP 2010507772 A JP2010507772 A JP 2010507772A JP 2010529950 A5 JP2010529950 A5 JP 2010529950A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- subject
- immunoreactive
- molecule
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91790607P | 2007-05-14 | 2007-05-14 | |
| US60/917,906 | 2007-05-14 | ||
| US4402808P | 2008-04-10 | 2008-04-10 | |
| US61/044,028 | 2008-04-10 | ||
| PCT/CA2008/000932 WO2008138139A1 (en) | 2007-05-14 | 2008-05-14 | Carbohydrate-containing pan cancer marker |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010529950A JP2010529950A (ja) | 2010-09-02 |
| JP2010529950A5 true JP2010529950A5 (enExample) | 2011-06-30 |
| JP5683948B2 JP5683948B2 (ja) | 2015-03-11 |
Family
ID=40001646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010507772A Active JP5683948B2 (ja) | 2007-05-14 | 2008-05-14 | 糖を含有する全ての（ｐａｎ）癌のマーカー |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8143373B2 (enExample) |
| EP (1) | EP2155250B1 (enExample) |
| JP (1) | JP5683948B2 (enExample) |
| CN (1) | CN102014955A (enExample) |
| AU (1) | AU2008250953B2 (enExample) |
| CA (1) | CA2687403A1 (enExample) |
| WO (1) | WO2008138139A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2841866A1 (en) * | 2010-07-14 | 2012-01-19 | Vancouver Biotech Ltd. | Carbohydrate hapten-based anti-cancer vaccines and antibody drugs |
| CN102901817A (zh) * | 2011-07-27 | 2013-01-30 | 北京大学 | Non-B Ig单抗RP215在细胞增殖、迁移及干细胞研究中的应用 |
| US8974786B2 (en) * | 2012-06-13 | 2015-03-10 | Vancouver Biotech Ltd. | Humanized antibodies to CA215 |
| CN105353132B (zh) * | 2015-11-13 | 2018-04-10 | 北京大学 | non B‑s IgG作为干/祖细胞标志物的应用 |
| CA3048312A1 (en) | 2017-01-01 | 2018-07-05 | Chi-Yu Gregory Lee | Rp215 chimeric antigen receptor construct and methods of making and using same |
| CN108484777B (zh) * | 2017-03-31 | 2022-07-12 | 李吉祐 | 人源化rp215单克隆抗体的嵌合抗原受体构建体及核酸分子与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| AU6031090A (en) * | 1989-07-31 | 1991-03-11 | University Of British Columbia, The | Monoclonal antibodies against a tumor-associated antigen |
| US6312924B1 (en) * | 1999-03-18 | 2001-11-06 | Zymogenetics, Inc. | Murine interferon-α |
| US6908612B2 (en) * | 1999-10-08 | 2005-06-21 | University Of Maryland Biotechnology Institute | Virus coat protein/receptor chimeras and methods of use |
| KR20040101428A (ko) * | 2002-04-09 | 2004-12-02 | 메르크 파텐트 게엠베하 | 항유전인자형 항-ｃｅａ 항체 분자 및 암백신으로서의이의 용도 |
| WO2005037261A1 (en) * | 2003-10-14 | 2005-04-28 | Biomira, Inc. | Combination therapy for cancer |
-
2008
- 2008-05-14 EP EP08757092.5A patent/EP2155250B1/en active Active
- 2008-05-14 CA CA002687403A patent/CA2687403A1/en not_active Abandoned
- 2008-05-14 AU AU2008250953A patent/AU2008250953B2/en not_active Ceased
- 2008-05-14 CN CN200880001243XA patent/CN102014955A/zh active Pending
- 2008-05-14 WO PCT/CA2008/000932 patent/WO2008138139A1/en not_active Ceased
- 2008-05-14 US US12/599,284 patent/US8143373B2/en active Active - Reinstated
- 2008-05-14 JP JP2010507772A patent/JP5683948B2/ja active Active
-
2012
- 2012-03-22 US US13/427,109 patent/US20120177636A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6622363B2 (ja) | 抗リポアラビノマンナン抗体及び当該抗体を用いた抗酸菌症のイムノアッセイ | |
| JP6539709B2 (ja) | 潜在的有害作用リスクのある患者にＣＤ１９ｘＣＤ３二特異性抗体を投与するための投薬レジメン | |
| JP2024161509A5 (enExample) | ||
| US9758586B2 (en) | Chimeric rabbit/human ROR1 antibodies | |
| EP3649152B1 (en) | Ror1 antibodies | |
| JP2019523651A5 (enExample) | ||
| WO2013188864A4 (en) | Anti-cd22 anti-idiotypic antibodies and uses thereof | |
| JP2010529950A5 (enExample) | ||
| JP2014531409A5 (enExample) | ||
| JP2014502253A5 (enExample) | ||
| JP2012515551A5 (enExample) | ||
| JP2019520034A5 (enExample) | ||
| JP2008545145A5 (enExample) | ||
| JP2020534012A5 (enExample) | ||
| ES2155450T5 (es) | Anticuerpos opsonicos fuertemente reactivos, que reaccionan a los antigenos comunes de los staphylococcus. | |
| JP2009536818A5 (enExample) | ||
| WO2018064013A1 (en) | METHODS FOR TREATING CANCER WITH BAVITUXIMAB BASED ON LEVELS OF β2-GLYCOPROTEIN 1, AND ASSAYS THEREFOR | |
| WO2023076881A1 (en) | Single domain antibodies targeting the s2 subunit of sars-cov-2 spike protein | |
| JP7366353B2 (ja) | 抗インドキシル硫酸の単離されたモノクローナル抗体及び／又はその抗原結合断片の組成物及びその用途 | |
| PT2432804E (pt) | Anticorpos ou seus fragmentos direcionados contra um epítopo de staphylococcus aureus de isaa ou isab | |
| JP5683948B2 (ja) | 糖を含有する全ての（ｐａｎ）癌のマーカー | |
| JP2018529328A5 (enExample) | ||
| WO2017149122A1 (en) | Clinical assessment of m-protein response in multiple myeloma | |
| JP2012503634A5 (enExample) | ||
| Giffon et al. | 711 IGM-7354 is an anti-PD-L1 IgM antibody and IL-15 cytokine fusion that enhances NK and CD8+ T cell proliferation and tumor cytotoxicity plus potently reverses T cell exhaustion |